Labcorp Holdings LH
NYSE LH
$322.83 -1.68 (-0.52%)
As of: Sep 17, 2026 · 3:59 PM EDT

Labcorp Holdings (LH) Income from Discontinued Operations (2022 - 2023)

Labcorp Holdings' (LH) quarterly Income from Discontinued Operations came in at $33.9 million in Q2 2023, down 62.71% year-over-year from $90.9 million in Q2 2022, and up 591.84% quarter-over-quarter from $4.9 million in Q1 2023.

Analysis

Labcorp Holdings (LH) Income from Discontinued Operations (2022 - 2023) Analysis & Trends

Labcorp Holdings has disclosed Income from Discontinued Operations across 2 years of filings, most recently posting $33.9 million for Q2 2023.

  • In Q2 2023, Income from Discontinued Operations fell 62.71% year-over-year to $33.9 million; the TTM figure through Mar 2024 stood at $33.9 million (down 83.93% YoY), while the FY2023 annual figure was $38.8 million, down 86.0% from the prior year.
  • Income from Discontinued Operations came in at $33.9 million for Q2 2023 at Labcorp Holdings, up from $4.9 million in the prior quarter.
  • In the past five years, Income from Discontinued Operations ranged from a high of $90.9 million in Q2 2022 to a low of $4.9 million in Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn -
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 33.90 Mn
Mar 31, 2023 4.90 Mn
Dec 31, 2022 39.30 Mn
Sep 30, 2022 75.90 Mn
Jun 30, 2022 90.90 Mn